In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood

Transfusion

Volumn 51, Issue 7, 2011, Pages 1460-1468

  Cancelas, Jose A ^a,b   Rugg, Neeta ^a,b   Fletcher, Dana ^a,b   Pratt, P Gayle ^a,b   Worsham, D Nicole ^a,b   Dunn, Susan K ^a,b   Marschner, Susanne ^a,b   Reddy, Heather L ^a,b   Goodrich, Raymond P ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARBON DIOXIDE; POTASSIUM; RIBOFLAVIN; SODIUM;

ARTICLE; CELL VIABILITY; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROCYTE METABOLISM; ERYTHROCYTE PRESERVATION; HEMOLYSIS; HUMAN; HUMAN CELL; PLASMA; THROMBOCYTE; ULTRAVIOLET RADIATION;

EID: 79960172472     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.03027.x     Document Type: Article

References (30)

1. Rock G,. A comparison of methods of pathogen inactivation of FFP. Vox Sang 2010. [Epub ahead of print].
2. Klein HG, Dodd RY, Dzik WH, Luban NL, Ness PM, Pisciotto P, Schiff PD, Snyder EL,. Current status of solvent/detergent-treated frozen plasma. Transfusion 1998; 38: 102-7. (Pubitemid 28090950)
3. Benjamin RJ, McCullough J, Mintz PD, Snyder E, Spotnitz WD, Rizzo RJ, Wages D, Lin JS, Wood L, Corash L, Conlan MG,. Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients. Transfusion 2005; 45: 1739-49. (Pubitemid 43923901)
4. Hendrickson JE, Hillyer CD,. Noninfectious serious hazards of transfusion. Anesth Analg 2009; 108: 759-69.
5. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-48. (Pubitemid 47498679)
6. Vamvakas EC, Blajchman MA,. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113: 3406-17.
7. Heddle NM,. Universal leukoreduction and acute transfusion reactions: putting the puzzle together. Transfusion 2004; 44: 1-4. (Pubitemid 38177128)
8. Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R,. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006; 46: 1553-60. (Pubitemid 44326331)
9. Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP,. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004; 80: 15-21.
10. Goodrich RP, Doane S, Reddy HL,. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Biologicals 2010; 38: 20-30.
11. Martin CB, Wilfong E, Ruane P, Goodrich R, Platz M,. An action spectrum of the riboflavin-photosensitized inactivation of Lambda phage. Photochem Photobiol 2005; 81: 474-80. (Pubitemid 40551528)
12. Usry RT, Moore GL, Manalo FW,. Morphology of stored, rejuvenated human erythrocytes. Vox Sang 1975; 28: 176-83.
13. Bandarenko N, Cancelas J, Snyder EL, Hay SN, Rugg N, Corda T, Joines AD, Gormas JF, Pratt GP, Kowalsky R, Rose M, Rose L, Foley J, Popovsky MA,. Successful in vivo recovery and extended storage of additive solution (AS)-5 red blood cells after deglycerolization and resuspension in AS-3 for 15 days with an automated closed system. Transfusion 2007; 47: 680-6. (Pubitemid 46449629)
14. Recommended method for radioisotope red-cell survival studies. International Committee for Standardization in Haematology. Br J Haematol 1980; 45: 659-66.
15. Keegan TB, Heaton A, Holme S, Owens M, Nelson EJ,. Improved post-transfusion quality of density separated AS-3 red cells after extended storage. Br J Haematol 1992; 82: 114-21.
16. Hornsey VS, Drummond O, Morrison A, McMillan L, MacGregor IR, Prowse CV,. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins. Transfusion 2009; 49: 2167-72.
17. Larrea L, Calabuig M, Roldan V, Rivera J, Tsai HM, Vicente V, Roig R,. The influence of riboflavin photochemistry on plasma coagulation factors. Transfus Apher Sci 2009; 41: 199-204.
18. Smith J, Rock G,. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma. Transfusion 2010; 50: 926-31.
19. AuBuchon JP, Pickard CA, Herschel LH, Roger JC, Tracy JE, Purmal A, Chapman J, Ackerman S, Beach KJ,. Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study. Transfusion 2002; 42: 146-52.
20. Rios JA, Hambleton J, Viele M, Rugg N, Sindermann G, Greenwalt T, Wages D, Cook D, Corash L,. Viability of red cells prepared with S-303 pathogen inactivation treatment. Transfusion 2006; 46: 1778-86. (Pubitemid 44435731)
21. Cancelas JA, Dumont LJ, Herschel L, Roger J, Rugg N, Garraty G, Arndt P, Propst P, Corash L, Sundin D, AuBuchon J,. A randomized, controlled, 2-period crossover study of recovery and lifespan of radiolabeled autologous 35-day-old red blood cells prepared with a modified S-303 treatment for pathogen inactivation. Vox Sang 2008; 95 (Suppl 1): 8.
22. Mufti NA, Erickson AC, North AK, Hanson D, Sawyer L, Corash LM, Lin L,. Treatment of whole blood (WB) and red blood cells (RBC) with S-303 inactivates pathogens and retains in vitro quality of stored RBC. Biologicals 2010; 38: 14-9.
23. Dumont LJ, AuBuchon JP,. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-60. (Pubitemid 351793478)
24. Moroff G, Holme S, AuBuchon JP, Heaton WA, Sweeney JD, Friedman LI,. Viability and in vitro properties of AS-1 red cells after gamma irradiation. Transfusion 1999; 39: 128-34. (Pubitemid 29085132)
25. Li J, Goodrich L, Hansen E, Edrich R, Gampp D, Goodrich RP,. Platelet glycolytic flux increases stimulated by ultraviolet-induced stress is not the direct cause of platelet morphology and activation changes: possible implications for the role of glucose in platelet storage. Transfusion 2005; 45: 1750-8. (Pubitemid 43923902)
26. Heaton WA,. Evaluation of posttransfusion recovery and survival of transfused red cells. Transfus Med Rev 1992; 6: 153-69.
27. Ataullakhanov FI, Vitvitsky VM, Zhabotinsky AM, Pichugin AV, Platonova OV, Kholodenko BN, Ehrlich LI,. The regulation of glycolysis in human erythrocytes. The dependence of the glycolytic flux on the ATP concentration. Eur J Biochem 1981; 115: 359-65. (Pubitemid 11103638)
28. Custer B, Agapova M, Martinez RH,. The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model. Transfusion 2010; 50: 2461-73.
29. Kauvar DS, Holcomb JB, Norris GC, Hess JR,. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006; 61: 181-4. (Pubitemid 44098342)
30. Spinella PC,. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Crit Care Med 2008; 36 (Suppl): S340-5.